gdc
Melanoma

Drugs for Skin Cancer

Here are the financial support services available to patients receiving treatment for Skin Cancer.

Bavencio (avelumab) Injection

Drug company: EMD Serono
844-826-8371

Bavencio is a PD-L1 inhibitor used for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel-cell carcinoma.

EMD Serono’s CoverOne offers 2 financial assistance programs for patients using Bavencio:

CoverOne Co-Pay Assistance Program

Through this program, patients with private insurance will be responsible for a $10 copay at participating medical facilities and pharmacies, and may be eligible for copay assistance up to a maximum of $30,000 per year.

CoverOne Patient Assistance Program

This program provides Bavencio at no charge for patients who meet certain income, insurance, and residency eligibility criteria.

Erivedge (vismodegib) Capsules

Drug company: Genentech
866-422-2377

Erivedge is a hedgehog pathway inhibitor used for the treatment of patients with metastatic basal-cell carcinoma or locally advanced basal-cell carcinoma.

Genentech offers 2 financial assistance programs for patients using Erivedge:

Genentech BioOncology Co-pay Card

For patients with insurance, the program ensures a $25 copay, with up to $25,000 provided annually. This program has no income requirements for participation.

Genentech Access to Care Foundation

This foundation provides Erivedge free of charge to uninsured and underinsured patients whose annual household income is less than $100,000. Erivedge is also provided free of charge for patients whose household income is less than $150,000 and whose out-of-pocket prescription costs exceed 5% of their income (regardless of insurance).

Odomzo (sonidegib) Capsules

Drug company: Sun Pharma
844-563-6696

Odomzo is a hedgehog pathway inhibitor used for the treatment of adults with locally advanced basal-cell carcinoma that has relapsed after surgery or radiation therapy, or in patients not candidates for surgery or radiation therapy.

Sun Pharma provides 2 financial assistance programs for patients using Odomzo:

Odomzo Copay Program

Patients with private insurance who are eligible for this program will pay as little as $10 per month for a prescription of Odomzo, with a maximum benefit of $15,000 a year.

Odomzo Patient Access Program

This program verifies the patient’s health insurance and out-of-pocket costs for Odomzo. Program coordinators will evaluate the patient’s eligibility for financial assistance based on certain medical and financial criteria.

Table. Drugs Prescribed for Skin Cancer

  • Drug name (generic name)
  • Drug company
  • Indication
  • Patient support services


    Drug name (generic name)
  • Odomzo (sonidegib) Capsules
  • Drug company
  • Sun Pharma
  • Indication
  • Locally advanced basal-cell carcinoma that relapsed after surgery or radiation or cannot be removed by surgery or radiation
  • Patient support services
  • Odomzo Copay Program
    877-636-6961

    Odomzo Patient Access Program
    844-563-6696

Last modified: April 25, 2018

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country